Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

The therapy is a critical treatment option for various life-threatening disease. Earlier, GST on gene therapy was set at 12 ...

National Institute of Standards and Technology scientists looked at multiple techniques used to measure the modified viruses ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Now new data from the programme, shared with the PA news agency, show that 235 people have been identified as having a higher ...

Investigators from Baylor College of Medicine, Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor, Houston Methodist Hospital and Texas Children's Hospital examined how ...

As it works to build a 775-acre research campus in the Florida heat, the Moffitt Cancer Center is looking to cool things down ...

Cancer metastasis—the spread of cancer to other organs—is the leading cause of death among cancer patients. Researchers have ...

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc’s blockbuster Tagrisso in a ...